STOCK WATCH

A CONTRACT win sent shares in science IT company Instem soaring yesterday.

The AIM-listed business said that a ‘top five pre-clinical’ research organisation has signed a contract extension to use its Send platform, which allows a more efficient review of information.

The contract is worth more than £350,000.

Twenty-five firms wanted to sign up to the platform in the two months to February 28.

Shares rocketed 19.4pc, or 36.5p, to 225p.